OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
No Cytotoxic and Inflammatory Effects of Empagliflozin and Dapagliflozin on Primary Renal Proximal Tubular Epithelial Cells under Diabetic Conditions In Vitro
Patrick C. Baer, Benjamin Koch, Janina Freitag, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 391-391
Open Access | Times Cited: 15
Patrick C. Baer, Benjamin Koch, Janina Freitag, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 391-391
Open Access | Times Cited: 15
Showing 15 citing articles:
Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
Mihai-Emil Gherghina, Ileana Peride, Mirela Ţigliş, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3188-3188
Open Access | Times Cited: 237
Mihai-Emil Gherghina, Ileana Peride, Mirela Ţigliş, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3188-3188
Open Access | Times Cited: 237
Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics
Gert Mayer, Christoph Wanner, Matthew R. Weir, et al.
Kidney International (2019) Vol. 96, Iss. 2, pp. 489-504
Open Access | Times Cited: 88
Gert Mayer, Christoph Wanner, Matthew R. Weir, et al.
Kidney International (2019) Vol. 96, Iss. 2, pp. 489-504
Open Access | Times Cited: 88
Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db/db mice and high glucose–treated HK-2 cells
Yanli Guo, Ran Zheng, Yong‐Wei Zhang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110684-110684
Open Access | Times Cited: 57
Yanli Guo, Ran Zheng, Yong‐Wei Zhang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110684-110684
Open Access | Times Cited: 57
Effect of sodium-glucose co-transporter 2 inhibitor on contrast-induced acute kidney injury and prognosis in type 2 diabetes patients undergoing percutaneous coronary intervention
Shicheng Yang, Huifang Hao, Xiangwei Zhai, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Shicheng Yang, Huifang Hao, Xiangwei Zhai, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems—A Literature Review
Viviana Elian, Violeta Popovici, Oana Karampelas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1972-1972
Open Access | Times Cited: 3
Viviana Elian, Violeta Popovici, Oana Karampelas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1972-1972
Open Access | Times Cited: 3
Co-localization of the sodium-glucose co-transporter-2 channel (SGLT-2) with endothelin ETA and ETB receptors in human cardiorenal tissue
Thomas L. Williams, Rhoda E. Kuc, Anna Paterson, et al.
Bioscience Reports (2024) Vol. 44, Iss. 6
Open Access | Times Cited: 3
Thomas L. Williams, Rhoda E. Kuc, Anna Paterson, et al.
Bioscience Reports (2024) Vol. 44, Iss. 6
Open Access | Times Cited: 3
Kidney Inflammation, Injury and Regeneration
Patrick C. Baer, Benjamin Koch, Helmut Geiger
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1164-1164
Open Access | Times Cited: 17
Patrick C. Baer, Benjamin Koch, Helmut Geiger
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1164-1164
Open Access | Times Cited: 17
Gliflozins Have an Anti-Inflammatory Effect on Renal Proximal Tubular Epithelial Cells in a Diabetic and Inflammatory Microenvironment In Vitro
Benjamin Koch, Dominik C. Fuhrmann, Ralf Schubert, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1811-1811
Open Access | Times Cited: 5
Benjamin Koch, Dominik C. Fuhrmann, Ralf Schubert, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1811-1811
Open Access | Times Cited: 5
Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy
Vjera Mihaljević, Milorad Zjalić, Tomislav Kizivat, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2983-2983
Open Access | Times Cited: 7
Vjera Mihaljević, Milorad Zjalić, Tomislav Kizivat, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2983-2983
Open Access | Times Cited: 7
The effect of dapagliflozin on myocardial ischemia–reperfusion injury in diabetic rats
Shilong Xiong, Donghua Mo, Yingjun Wu, et al.
Canadian Journal of Physiology and Pharmacology (2023) Vol. 101, Iss. 2, pp. 80-89
Closed Access | Times Cited: 3
Shilong Xiong, Donghua Mo, Yingjun Wu, et al.
Canadian Journal of Physiology and Pharmacology (2023) Vol. 101, Iss. 2, pp. 80-89
Closed Access | Times Cited: 3
Research Progress on the Application of Dapagliflozin in the Treatment of Chronic Kidney Disease
水发 汪
Advances in Clinical Medicine (2024) Vol. 14, Iss. 01, pp. 2255-2260
Closed Access
水发 汪
Advances in Clinical Medicine (2024) Vol. 14, Iss. 01, pp. 2255-2260
Closed Access
Mutagenic and genotoxic in silico QSAR prediction of dimer impurity of gliflozins; canagliflozin, dapaglifozin, and emphagliflozin and in vitro evaluation by Ames and micronucleus test
Rajesh A. Rane, Bharat Satpute, Dileep Kumar, et al.
Drug and Chemical Toxicology (2024), pp. 1-10
Closed Access
Rajesh A. Rane, Bharat Satpute, Dileep Kumar, et al.
Drug and Chemical Toxicology (2024), pp. 1-10
Closed Access
Empagliflozin’s role in early tubular protection for type 2 diabetes patients
Chuangbiao Zhang, Weiwei Ren, Xiaohua Lü, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
Chuangbiao Zhang, Weiwei Ren, Xiaohua Lü, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
Inhibitory Effect of Gliquidone on Epithelial-to-Mesenchymal-Transition of Renal Tubular Epithelial Cells Under Diabetic Nephropathy Mouse Model
Ting Liu, Jie Chen, Yiying Ying, et al.
Journal of Biomaterials and Tissue Engineering (2021) Vol. 12, Iss. 1, pp. 71-80
Closed Access | Times Cited: 1
Ting Liu, Jie Chen, Yiying Ying, et al.
Journal of Biomaterials and Tissue Engineering (2021) Vol. 12, Iss. 1, pp. 71-80
Closed Access | Times Cited: 1
Analysis of dapagliflozin-induced expression profile of long noncoding RNAs in proximal tubular epithelial cells of diabetic kidney disease
Yi Song, Feng Guo, Fengjuan Huang, et al.
Diabetic Nephropathy (2021) Vol. 1, Iss. 2, pp. 77-89
Open Access
Yi Song, Feng Guo, Fengjuan Huang, et al.
Diabetic Nephropathy (2021) Vol. 1, Iss. 2, pp. 77-89
Open Access
